LIFE SCIENCES CASE STUDY
Early-Stage Australian Baby Skincare Brand
AICIS-registered, Australian-developed, overseas-manufactured, dermatologically tested. All the boxes were ticked. Standard markets still declined. We placed it with a specialist.
THE SITUATION
A new Australian consumer product business approached us to place Product Liability cover before launching a dermatologically tested baby skincare product. The brand is early-stage and pre-revenue, but the compliance story is strong:
- The formulation is Australian-developed and registered with the Australian Industrial Chemicals Introduction Scheme (AICIS)
- Manufacturing is outsourced overseas to a GMP-aligned facility
- The product has been through Australian dermatological testing
On paper, this is a well-built product from a cautious, compliance-minded founder. In practice, "new baby skincare brand" is still a hard occupation to place through standard markets.
OUR APPROACH
The instinct for a new founder is to go to an online panel, but the reality is that those panels aren't built for this risk. In this case, all of the standard markets accessible through a major online quote platform declined.
We pivoted to a specialist market that underwrites consumer chemical products. The submission emphasised:
- The AICIS registration status
- The Australian dermatological testing evidence
- The distribution channel and target customer base
- The founder's realistic projected turnover and product volumes
THE CHALLENGES
Two things made this placement harder than it looks on the surface.
First, "baby" as an occupation descriptor triggers the most conservative settings in every underwriter's appetite. Anything sold for use on infants attracts the highest level of underwriting scrutiny because the downstream claims environment is more emotionally charged and the settlements skew higher.
Second, it's a pre-revenue business. A new brand with no claims history, no trading history and no established distribution pattern is a blank sheet for underwriters to fill in. Without a broker pushing the right story, most will just decline.
THE OUTCOME
We placed Product Liability cover for the baby skincare brand through a specialist market at an annual premium of around $2,900.
The client walked away with a policy that lets them launch, distribute and sell. That's the entire point. No cover means no retailer will stock the product and no platform will list it.
If you're launching an AICIS-registered consumer chemical product in Australia and the mainstream markets have come back with declines, the next step isn't "try a different online form". It's reaching a specialist underwriter that writes this work. More on how we place these risks on our life sciences insurance page, or see our broader guide to product liability insurance.
Put this placement in context
More Case Studies
All case studiesMaternity Therapeutic Device Hire Business
A specialist maternity support business hiring low-voltage therapeutic devices to expectant clients. PL and Product Liability placed after multiple standard insurer declines.
Read case study Life SciencesChildren's Consumer Products Importer, Metro Sydney
A Sydney importer of children's mealtime goods compliant with Australian mandatory safety standards. $20M Public and Product Liability placed at around $1,200.
Read case study Life SciencesBiomedical R&D Consultant, Implantable Device Experience
A biomedical R&D consultant advising on biocompatibility for implantable medical devices. Combined PI and PL placed through a specialist underwriter after a handful of occupation-based declines.
Read case studyGot a Life Sciences Risk That's Been Declined?
A few declines doesn't mean you're uninsurable. It usually means the submission hasn't reached the right market yet. Talk to our team about how we place life sciences, biotech, medical device and consumer chemical risks.